Whether a patient has a diagnosis of cPTSD, BPD, or some combination of both, treatment should be considered multifaceted and overlapping. Learn more in this Special Report article.
This book provides a comprehensive overview of the most sustained comprehensive mental health recovery and research program implemented after a natural disaster.
Addiction among older adults is associated with worse medical outcomes and increased economic burden of care. The long-term use of psychoactive substances can result in adverse neurological outcomes even at therapeutic doses.
How can offering hope for chronic illness make healing possible for us all?
How is the Sigourney Award helping expand the boundaries of psychoanalytic thinking?
Loss of smell can be devastating for patients. How can psychiatrists deal with the associated psychological effects?
How can we, as clinicians, understand how trauma has affected our patients and respond in the most effective way?
Are there parts of the movie “It Ends With Us” that could have suicide protective effects for viewers?
In overdose, cyproheptadine may cause central nervous system depression and sedation, as well as anticholinergic syndrome.
Inhalant use disorder is a form of substance use disorder characterized by the intentional inhalation of volatile substances for their psychoactive effects.
Prepare your patients for the Fourth of July with expert tips from Roger Rivera, FNP, PMHNP, DNP, on managing risky behaviors, adherence distractions, PTSD-related triggers, and sensory overload during the holiday.
The need for brain skills comes at a time of historically poor brain health. What can be done to help?
In this CME article, learn more about the common neuropsychiatric sequelae of post-acute sequelae of COVID-19, the underlying neurobiological mechanisms, and evidence-based treatments and interventions.
"In regard to psychiatric hospitalizations, the principles of ethics are imperative in determining how to proceed in each case."
In this video, Jamie Tworkowski, founder of a suicide awareness organization, shares the story of the charity's surprising start.
A case report and literature review of intrathecal methotrexate-induced mania.
Learn more about a condition that is often underestimated and mistaken for typical premenstrual symptoms or mood swings: premenstrual dysphoric disorder.
The COVID-19 pandemic reveals existing weaknesses in the mental health system, but also presents opportunities for reform.
Emergency departments face unique challenges in providing psychiatric care for individuals with intellectual and developmental disabilities, impacting wait times and overall experience.
What should you know about the lesser known psychedelics? Clinical insights from Jacob Perlson, MD, MPH, at the APA Annual Meeting.
This book provides a comprehensive overview of the most sustained comprehensive mental health recovery and research program implemented after a natural disaster.
Here's why psychedelics might be a valuable addition to mental health treatment.
Learn how best to facilitate catatonia assessment via telepsychiatry in this 3-case example article.
How can you communicate the diagnosis in a way that relieves suffering and helps patients and their caregivers prepare for the future?
Learn more about the critical link between early adversity and psychosis, and the need for targeted interventions and preventive measures.
Fathers share their heartbreaking stories of loss and advocate for a new model of suicide prevention that emphasizes early intervention and awareness at the 2025 APA Annual Meeting.
Euthanasia risks becoming a symptom of burnout.